COVID-19 in China: From epidemiology to treatment (Review)

Coronavirus disease 2019 (COVID-19) is a newly emerging infectious disease caused by the novel coronavirus SARS-CoV-2. It first became prevalent in Wuhan, Hubei, China in December 2019. COVID-19 was initially characterized by pneumonia of unknown etiology, accompanied by fever, dry cough and fatigue...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Hongtao, Wu, Shipin, Zhang, Xiaoyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646693/
https://www.ncbi.nlm.nih.gov/pubmed/33193837
http://dx.doi.org/10.3892/etm.2020.9353
_version_ 1783606834222858240
author Chen, Hongtao
Wu, Shipin
Zhang, Xiaoyong
author_facet Chen, Hongtao
Wu, Shipin
Zhang, Xiaoyong
author_sort Chen, Hongtao
collection PubMed
description Coronavirus disease 2019 (COVID-19) is a newly emerging infectious disease caused by the novel coronavirus SARS-CoV-2. It first became prevalent in Wuhan, Hubei, China in December 2019. COVID-19 was initially characterized by pneumonia of unknown etiology, accompanied by fever, dry cough and fatigue. Due to its highly infectious nature it rapidly led to widespread human infection, causing 80,924 confirmed cases and 3,140 mortalities in mainland China as of March 9, 2020. The present review highlights the prevalence of COVID-19 in China, the etiology, pathology, clinical presentation, laboratory and chest imaging tests, and treatment of this disease.
format Online
Article
Text
id pubmed-7646693
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-76466932020-11-13 COVID-19 in China: From epidemiology to treatment (Review) Chen, Hongtao Wu, Shipin Zhang, Xiaoyong Exp Ther Med Review Coronavirus disease 2019 (COVID-19) is a newly emerging infectious disease caused by the novel coronavirus SARS-CoV-2. It first became prevalent in Wuhan, Hubei, China in December 2019. COVID-19 was initially characterized by pneumonia of unknown etiology, accompanied by fever, dry cough and fatigue. Due to its highly infectious nature it rapidly led to widespread human infection, causing 80,924 confirmed cases and 3,140 mortalities in mainland China as of March 9, 2020. The present review highlights the prevalence of COVID-19 in China, the etiology, pathology, clinical presentation, laboratory and chest imaging tests, and treatment of this disease. D.A. Spandidos 2020-12 2020-10-15 /pmc/articles/PMC7646693/ /pubmed/33193837 http://dx.doi.org/10.3892/etm.2020.9353 Text en Copyright: © Chen et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Review
Chen, Hongtao
Wu, Shipin
Zhang, Xiaoyong
COVID-19 in China: From epidemiology to treatment (Review)
title COVID-19 in China: From epidemiology to treatment (Review)
title_full COVID-19 in China: From epidemiology to treatment (Review)
title_fullStr COVID-19 in China: From epidemiology to treatment (Review)
title_full_unstemmed COVID-19 in China: From epidemiology to treatment (Review)
title_short COVID-19 in China: From epidemiology to treatment (Review)
title_sort covid-19 in china: from epidemiology to treatment (review)
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646693/
https://www.ncbi.nlm.nih.gov/pubmed/33193837
http://dx.doi.org/10.3892/etm.2020.9353
work_keys_str_mv AT chenhongtao covid19inchinafromepidemiologytotreatmentreview
AT wushipin covid19inchinafromepidemiologytotreatmentreview
AT zhangxiaoyong covid19inchinafromepidemiologytotreatmentreview

Ejemplares similares